A Prominent Role for Mucosal Cystine/Cysteine Metabolism in Intestinal Immunoregulation

Gastroenterology

Volumn 134, Issue 1, 2008, Pages 179-191

  Sido, Bernd ^a   Lasitschka, Felix ^a   Giese, Thomas ^a   Gassler, Nikolaus ^b   Funke, Benjamin ^a   Schröder Braunstein, Jutta ^a   Brunnemer, Ulf ^a   Meuer, Stefan C ^a   Autschbach, Frank ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTINE; GLUTATHIONE; MESSENGER RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTERITIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOREGULATION; IN VITRO STUDY; LAMINA PROPRIA; METABOLISM; MICROENVIRONMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SPECTROPHOTOMETRY; T LYMPHOCYTE;

EID: 37349001991     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.11.001     Document Type: Article

References (40)

1. Jump R.L., and Levine A.D. Mechanisms of natural tolerance in the intestine. Inflamm Bowel Dis 10 (2004) 462-478
2. Pirzer U., Schönhaar A., Fleischer B., et al. Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease. Lancet 338 (1991) 1238-1239
3. Qiao L., Golling M., Autschbach F., et al. T-cell receptor repertoire and mitotic responses of lamina propria T lymphocytes in inflammatory bowel disease. Clin Exp Immunol 97 (1994) 303-308
4. Duchmann R., Kaiser I., Hermann E., et al. Tolerance exists towards resident intestinal microflora but is broken in active inflammatory bowel disease. Clin Exp Immunol 102 (1995) 448-455
5. Macpherson A., Khoo U.Y., Forgacs I., et al. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38 (1996) 365-375
6. Rugtveit J., Brandtzaeg P., Halstensen T.S., et al. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 35 (1994) 669-674
7. Burgio V.L., Fais S., Boirivant M., et al. Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. Gastroenterology 109 (1995) 1029-1038
8. Grimm M.C., Pullman W.E., Bennett G.M., et al. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J Gastroenterol Hepatol 10 (1995) 387-395
9. Mahida Y.R. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 6 (2000) 21-33
10. Sido B., Braunstein J., Breitkreutz R., et al. Thiol-mediated redox regulation of intestinal lamina propria T-lymphocytes. J Exp Med 192 (2000) 907-912
11. Ishii T., Sugita Y., and Bannai S. Regulation of glutathione levels in mouse spleen lymhocytes by transport of cysteine. J Cell Physiol 133 (1987) 330-336
12. Staal F.J.T., Anderson M.T., Staal G.E., et al. Redox regulation of signal transduction: tyrosine phosphorylation and calcium influx. Proc Natl Acad Sci U S A 91 (1994) 3619-3622
13. Gmünder H., Eck H.P., and Dröge W. Low membrane transport activity for cystine in resting and mitogenically stimulated human lymphocyte preparations and human T cell clones. Eur J Biochem 201 (1991) 113-117
14. Mansoor M.A., Svardal A.M., and Ueland P.M. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem 200 (1992) 218-229
15. Gmünder H., Eck H.P., Benninghoff B., et al. Macrophages regulate intracellular glutathione levels of lymphocytes. Evidence for an immunoregulatory role of cysteine. Cell Immunol 129 (1990) 32-46
16. Eck H.P., and Dröge W. Influence of the extracellular glutamate concentration on the intracellular cyst(e)ine concentration in macrophages and on the capacity to release cysteine. Biol Chem Hoppe-Seyler 370 (1989) 109-113
17. Sido B., Breitkreutz R., Seel C., et al. Redox processes regulate intestinal lamina propria T lymphocytes. Methods Enzymol 352 (2002) 232-247
18. Qiao L., Braunstein J., Golling M., et al. Differential regulation of human T-cell responsiveness by mucosal vs blood monocytes. Eur J Immunol 26 (1996) 922-927
19. Autschbach F., Giese T., Gassler N., et al. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease. Virchows Arch 441 (2002) 500-513
20. Palace G.P., and Lawrence D.A. Phospholipid metabolism of lymphocytes with inhibited glutathione synthesis using L-buthionine-S,R-sulfoximine. Free Radic Biol Med 18 (1995) 709-720
21. -. Pflugers Arch 442 (2001) 286-296
22. Rugtveit J., Bakka A., and Brandtzaeg P. Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD). Clin Exp Immunol 110 (1997) 104-113
23. Soltaninassab S.R., Sekhar K.R., Meredith M.J., et al. Multi-faceted regulation of γ-glutamylcysteine synthetase. J Cell Physiol 182 (2000) 163-170
24. Messina J.P., and Lawrence D.A. Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase. J Immunol 143 (1989) 1974-1981
25. Kavanagh T.J., Grossmann A., Jaecks E.P., et al. Proliferative capacity of human peripheral blood lymphocytes sorted on the basis of glutathione content. J Cell Physiol 145 (1990) 472-480
26. Hamilos D.L., Zelarney P., and Mascali J.J. Lymphocyte proliferation in glutathione-depleted lymphocytes: direct relationship between glutathione availability and the proliferative response. Immunopharmacology 18 (1989) 223-235
27. Fidelus R.K., Ginouves P., Lawrence D., et al. Modulation of intracellular glutathione concentrations alters lymphocyte activation and proliferation. Exp Cell Res 170 (1987) 269-275
28. 2+ signaling in identified T-lymphocytes from human intestinal mucosa. J Biol Chem 279 (2004) 5641-5647
29. Staal F.J.T., Roederer M., Israelski D.M., et al. Intracellular glutathione levels in T-cell subsets decrease in HIV-infected individuals. AIDS Res Hum Retroviruses 8 (1992) 305-311
30. Dröge W., Eck H.P., Gmunder H., et al. Modulation of lymphocyte functions and immune responses by cysteine and cysteine derivatives. Am J Med 91 (1991) S140-S144
31. Smythies L.E., Sellers M., Clements R.H., et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 115 (2005) 66-75
32. Rogler G., Andus T., Aschenbrenner E., et al. Alterations of the phenotype of colonic macrophages in inflammatory bowel disease. Eur J Gastroenterol Hepatol 9 (1997) 893-899
33. Hausmann M., Kiessling S., Mestermann S., et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122 (2002) 1987-2000
34. Shanahan F. Crohn's disease. Lancet 359 (2002) 62-69
35. Swidsinski A., Ladhoff A., Pernthaler A., et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 122 (2002) 44-54
36. Cario E., Gerken G., and Podolsky D.K. For whom the bell tolls. Innate defense mechanisms and survival stategies of the intestinal epithelium against luminal pathogens. Z Gastroenterol 40 (2002) 983-990
37. Wehkamp J., Harder J., Weichenthal M., et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression. Gut 53 (2004) 1658-1664
38. Rogler G., Hausmann M., Vogl D., et al. Isolation and phenotypic characterization of colonic macrophages. Clin Exp Immunol 112 (1998) 205-215
39. Rugtveit J., Nilsen E.M., Bakka A., et al. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology 112 (1997) 1493-1505
40. Autschbach F., Schürmann G., Qiao L., et al. Cytokine messenger-RNA expression and proliferation status of intestinal mononuclear cells in noninflamed gut and Crohn's disease. Virchows Arch 426 (1995) 51-60